Amphastar Pharmaceuticals, Inc. (AMPH)
25.14
-0.90
(-3.46%)
USD |
NASDAQ |
Oct 23, 16:00
25.00
-0.14
(-0.56%)
After-Hours: 20:00
Amphastar Pharmaceuticals Market Cap : 1.069B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.069B |
| October 22, 2026 | 1.108B |
| October 21, 2026 | 1.114B |
| October 20, 2026 | 1.103B |
| October 19, 2026 | 1.112B |
| October 16, 2026 | 1.100B |
| October 15, 2026 | 1.124B |
| October 14, 2026 | 1.109B |
| October 13, 2026 | 1.108B |
| October 12, 2026 | 1.138B |
| October 09, 2026 | 1.132B |
| October 08, 2026 | 1.098B |
| October 07, 2026 | 1.086B |
| October 06, 2026 | 1.102B |
| October 05, 2026 | 1.079B |
| October 02, 2026 | 1.082B |
| October 01, 2026 | 1.078B |
| September 30, 2026 | 1.098B |
| September 29, 2026 | 1.135B |
| September 28, 2026 | 1.165B |
| September 25, 2026 | 1.111B |
| September 24, 2026 | 1.117B |
| September 23, 2026 | 1.062B |
| September 22, 2026 | 1.034B |
| September 21, 2026 | 1.041B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.005B |
| September 17, 2026 | 1.013B |
| September 16, 2026 | 1.019B |
| September 15, 2026 | 1.005B |
| September 14, 2026 | 1.017B |
| September 11, 2026 | 1.011B |
| September 10, 2026 | 1.001B |
| September 09, 2026 | 979.94M |
| September 08, 2026 | 975.26M |
| September 04, 2026 | 985.90M |
| September 03, 2026 | 1.014B |
| September 02, 2026 | 1.010B |
| September 01, 2026 | 976.54M |
| August 31, 2026 | 958.25M |
| August 28, 2026 | 936.13M |
| August 27, 2026 | 930.60M |
| August 26, 2026 | 936.56M |
| August 25, 2026 | 934.86M |
| August 24, 2026 | 915.29M |
| August 21, 2026 | 918.70M |
| August 20, 2026 | 922.10M |
| August 19, 2026 | 924.65M |
| August 18, 2026 | 907.64M |
| August 17, 2026 | 887.22M |
| August 14, 2026 | 889.35M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viatris, Inc. | 20.79B |
| Johnson & Johnson | 635.02B |
| Eli Lilly & Co. | 1.199T |
| Merck & Co., Inc. | 358.62B |
| Pfizer Inc. | 171.14B |
Market Cap Related Metrics
| PE Ratio | 14.73 |
| PS Ratio | 1.597 |
| Price to Book Value | 1.392 |
| Price to Free Cash Flow | 7.626 |
| Price | 25.14 |
| Earnings Yield | 6.79% |
| Operating PE Ratio | 10.20 |
| Normalized PE Ratio | 16.64 |